GlassScriptPhysician profile
John Andrew Cox
NPI 1699183160
$6,451.62
in general payments reported to CMS, 2019-2025
22 companies · $716 in 2025
The $716 reported for 2025 was more than what 87% of Neurocritical Care providers received nationally (typical 2025 total: $95.82).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.84 · 2020: $1,803 · 2021: $538 · 2022: $653 · 2023: $2,173 · 2024: $493 · 2025: $716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,933 · Travel and Lodging: $1,448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,933.48 |
| Travel and Lodging | $1,447.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Balt USA, LLC | $1,646.41 | 2023 | Eclipse 2l |
| Ge Healthcare | $975.45 | 2020 | |
| Philips North America LLC | $935.23 | 2020-2023 | |
| Depuy Synthes Sales INC. | $882.15 | 2019-2025 | Embotrap, Cerepak Uniform, Trufill |
| Penumbra, INC. | $542.94 | 2020-2021 | |
| Imperative Care, INC | $439.79 | 2022-2025 | Zoom 88-T Large Distal Platform, Zoom Rdl Radial Access System, 103cm, Zoom Reperfusion Catheter |
| Stryker Corporation | $242.28 | 2025 | Surpass Evolve, Broadway 8, Trevo |
| Chiesi USA, INC. | $186.38 | 2022-2024 | Cleviprex |
| Medtronic, INC. | $111.65 | 2021-2025 | Pipeline |
| Genzyme Corporation | $74.69 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $72.93 | 2023-2024 | Andexxa |
| Abbvie INC. | $57.64 | 2024 | |
| Ucb, INC. | $51.15 | 2022-2025 | Zilbrysq |
| Siemens Medical Solutions USA, INC. | $48.37 | 2020-2021 | |
| Scientia Vascular | $34.26 | 2022-2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $32.38 | 2025 | |
| Route 92 Medical, INC. | $28.56 | 2025 | |
| Life Molecular Imaging LTD | $21.97 | 2024 | Neuraceq |
| Catalyst Pharmaceuticals, INC. | $20.24 | 2023 | Firdapse |
| Amgen INC. | $18.97 | 2025 | |
| Inspiremd LTD | $15.19 | 2025 | Cguard Prime Carotid Stent System |
| Terumo Medical Corporation | $12.99 | 2023 | Glidewire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Andrew Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.